-
May 22, 2019 Lupin launches Budesonide Inhalation Suspension
-
May 15, 2019 Fiscal year 2019 Results
-
May 15, 2019 U.S. FDA completes inspection of Lupin’s Aurangabad facility
-
May 14, 2019 Lupin receives EIR for Pharmacovigilance inspection from the U.S. FDA
-
May 10, 2019 Lupin launches Clobazam Tablets
-
May 9, 2019 Lupin and Aptissen announce exclusive distribution agreement of Synolis VA for Canada
-
May 7, 2019 Lupin receives tentative U.S. FDA approval for Fosaprepitant for Injection
-
April 30, 2019 Lupin in alliance with Natco receives FDA approval for Bosentan Tablets
-
April 16, 2019 Lupin receives FDA approval for Fluoxetine Tablets USP
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications